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Backgrounds Prediction of left ventricular functional recovery is important after myocardial infarction. The impact of 
quantitative perfusion and motion analyses with gated single-photon emission computed tomography  (SPECT) on 
predictive ability has not been clearly defined in multi-center studies. 
Methods A total of 252 patients with recent myocardial infarction (n=74) and old myocardial infarction (n=175) were 
registered from 25 institutions. All patients underwent resting gated SPECT using 99mTc-MIBI, and repeated the study 
after revascularization after an average follow-up period of 132±81 days. Visual and quantitative assessment of 
perfusion and wall motion were performed in 5040 segments.  
Results Non-gated segmental %uptake and end-systolic (ES) %uptake were good predictors of wall motion recovery 
and significantly differed between improved and non-improved groups (66±17% and 55±18%, p<0.0001 for 
non-gated, 64±16% and 51±17% for ES %uptake, p<0.0001). The area under the curve (AUC) of receiver-operating 
characteristics curve (ROC) for non-gated %uptake, ES %uptake, end-diastolic (ED) %uptake and visual perfusion 
defect score was 0.70, 0.71, 0.61 and 0.56, respectively. Sensitivity and specificity of %uptake were 68% and 64% for 
non-gated map and 80% and 52% for ES %uptake map. An optimal threshold for predicting segmental improvement 
was 63% for non-gated and 52% for ES %uptake values. 
Conclusion Segmental 99mTc-MIBI uptake provided a useful predictor of wall motion improvement. Application of 
quantitative approach with non-gated and ES %uptake enhanced predictive accuracy over visual analysis particularly 
in a multi-center study.  
 
Keywords: 99mTc-hexakis-2-methoxy-isobutyl isonitrile (MIBI), viability, gated single-photon emission computed 





Predicting functional recovery before 
revascularization in patients with known coronary artery 
disease is important to determine indications for 
percutaneous coronary intervention (PCI) and coronary 
artery bypass grafting (CABG). Numerous experimental 
and clinical studies have demonstrated that when 
episodes of ischemia results in regional contractile 
dysfunction, restoration of perfusion will result in 
improvement in regional contractility. Even if some 
myocardial segments showed severe contractile 
dysfunction, left ventricular global and regional 
contractility may recover owing to viable segments. 
Non–invasive myocardial viability assessment thus has 
been considered important, and various approaches have 
been utilized including contractile functional reserve by 
echocardiography with inotropic stimulation, 
myocardial perfusion imaging with single-photon 
emission computed tomography (SPECT) and positron 
emission tomography with 18F-fuluorodeoxyglucose 
(FDG) [1-6]. Although FDG may provide better 
diagnostic ability for detecting potentially reversible 
myocardial dysfunction, single-photon myocardial 
perfusion tracers continue to be one of the best 
convenient choices for clinical practice. Prediction of 
regional functional recovery was successfully achieved 
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by 99mTc-hexakis-2-methoxy-isobutyl isonitrile (MIBI) 
SPECT as well as by 201Tl, and viable and non-viable 
segments could be differentiated [7-12].  
 Considering that many nuclear medicine 
facilities can perform gated SPECT, a quantitative 
approach for gated SPECT analysis has become a 
common diagnostic procedure [13]. Thus, prediction of 
viability using all available parameters would be 
potentially beneficial by the current use of quantitative 
gated SPECT. Currently available techniques for 
predicting functional recovery after revascularization 
was summarized by Bax et al. in 1997, and 37 studies 
were summarized [5]. The numbers of patients in each 
of the ten MIBI studies were less than 40, and only a 
few studies dealt with >100 patients even after that point 
on [12]. In addition, the studies were performed in a 
single center, and few multicenter studies have been 
performed. Thus, we designed a multi-center cohort 
study with participation of Japanese hospitals for 
predicting recovery of ventricular dysfunction using 
resting 99mTc-MIBI SPECT. The goal of this study was 
to determine the best predictor and threshold for 
viability assessment with quantitative analysis as well as 
visual segmental analysis, and apply them as a practical 
clinical indicator for revascularization. 
 
Materials and Methods 
 
Patients 
This study group for viability assessment 
began in July 2003 and final follow-up SPECT ended in 
March 2006. This research was a multi-center cohort 
study, prospectively performed. A total of 262 patients 
were registered from 25 institutions throughout Japan. 
The principal criteria for patient selection consisted of 
myocardial infarction documented by coronary 
angiography associated with left ventricular wall motion 
abnormality, and the patients were scheduled for 
coronary intervention. The inclusion criteria were (1) 
recent myocardial infarction (RMI) 7 to 30 days from 
the onset of myocardial infarction or old myocardial 
infarction (OMI, defined as > 30 days after onset) and 
(2) existence of regional wall motion abnormality before 
revascularization, (3) successful reperfusion without 
restenosis until the second post-intervention SPECT 
study, and (4) informed consent received from the 
patients. A pre-intervention SPECT study and coronary 
angiography should have been performed within one 
month of revascularization, and post-intervention 
follow-up SPECT was performed <1 year after the 
revascularization. However, during the follow-up and 
summary periods, 10 patients were excluded from the 
study, which included those with no segments of 
significant asynergy found in subsequent analysis (n=3), 
and segments of asynergy found only from the 
non-revascularized artery segments (n=5). In addition, 
because of a technical error during data transfer, data 
from 2 patients could not be analyzed. Finally, 252 
patients (216 males and 36 females) were judged 
optimal for subsequent data analysis (Table 1). The 
mean age was 67.1 ± 11.1 years. Out of the 252 patients, 
74 (29%) were diagnosed with RMI, 175 (69%) with 
OMI, and 3 (1%) with both RMI and OMI. The study 
protocol was approved by either the Review Board or 
the Ethical Committee of the participating institutes. 
Written informed consent was obtained from all patients 
who participated. 
 
Coronary arteriography and intervention 
 Coronary arteriography was performed in 
each hospital with standard techniques, and the coronary 
segments and stenosis were judged based on American 
Heart Association (AHA) criteria. The stenosis of 
coronary arteriography >75% was judged significant. 
The number of vessels involved was 140 one-vessel, 59 
two-vessel and 53 three-vessel diseases (Table 1). 
Percutaneous coronary intervention (PCI) was 
performed in 210 patients (83%) and coronary artery 
bypass grafting (CABG) in 40 patients (16%). 
Localization of infarction was right coronary artery 
(RCA) in 117 patients (46%), left anterior descending 
artery (LAD) in 150 (60%) and left circumflex artery 
(LCX) in 70 (28%). The presence of restenosis was 
judged by the combination of clinical information that 
included coronary arteriography (n=178, 71%), stress 
and rest myocardial perfusion SPECT, exercise and 
resting electrocardiography (ECG) and clinical signs 
and symptoms. 
 
Gated SPECT study 
An ECG-gated perfusion SPECT was 
obtained at rest using 99mTc-MIBI with a standard 
administration dose (300-1110 MBq). Gated SPECT 
was performed in all patients before and after 
revascularization. All institutes used a standard data 
acquisition protocol for the MIBI study, but the precise 
acquisition conditions were based on their routine 
settings. Out of 25 institutes, 20 used a two-detector 
system, and 5 used a three-detector system. A 
low-energy high-resolution collimator was used in 11 
institutes, a low-energy general-purpose collimator in 10 
institutes and a low-medium-energy general-purpose 
collimator in 4 institutes. The camera rotation range was 
360 degrees (n=14) and 180 degrees (n=11). All 
institutes used 64x64-matrix projection images. Pixel 
size ranged from 5.2 to 6.9 mm. The number of division 
per cardiac cycle was 16, 12, 10 and 8 frames in 12, 4, 1 
and 8 institutes, respectively. Rejection of arrhythmia 
was used in 17 institutes. Attenuation correction was 
performed in 2 institutes. A combination of Butterworth 
and ramp filters was used in all hospitals.  
 
SPECT data processing and image interpretation 
All projection images were transferred with 
a DICOM (Digital Imaging and Communications in 
Medicine) format to the core laboratory. Since multiple 
vendors were involved in the SPECT acquisition and 
reconstruction, the projection images were again 
reconstructed using the same reconstruction parameters 
(eNTEGRA workstation, GE Yokogawa Medical 
Systems, Ltd., Tokyo). The cutoff frequency of the 
Butterworth filter was 0.4 cycles/cm for gated images 
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and 0.4 – 0.5 cycles/cm for non-gated images with a 
slight difference depending on the image counting 
statistics.  After reconstruction of the gated short-axis 
slices, QGS software and QPS software (Cedars Sinai 
Medical Center, CA, USA) were used for visual 
interpretation and subsequently for quantitative analysis. 
Myocardial segments were divided into 20 segments 
with QGS and QPS, namely six basal segments, six mid 
segments, six apical segments in the short-axis slices, 
and 2 apical segments in the mid vertical long-axis slice 
[14]. The 20-segment model was validated well and 
found to show good correlation with a 17-segment 
model [15]. Correspondence of coronary artery territory 
to segments was RCA to the apical inferior, mid and 
basal inferoseptal and inferior segments (5 segments); 
LCX to the apical, mid and basal anterolateral and 
inferolateral segments (6 segments); and LAD to the 
remaining segments covering anterior, septal and the 
apex (9 segments). Regarding perfusion defects, defect 
scores were visually analyzed with five-point scoring in 
each segment; namely, normal (0), slightly decreased (1), 
moderately decreased (2), severely decreased (3), and 
complete defect (4). Regional wall motion was similarly 
analyzed with five-point scoring in 20 segments; namely, 
normokinesis (0), mild hypokinesis (1), severe 
hypokinesis (2), akinesis (3) and dyskinesis (4). The 
wall motion was interpreted using only motion display 
of the short-axis and vertical long-axis views without 
information of quantitative analysis.  
 
Interobserver variability of interpretation 
The existence of perfusion defect and 
segmental asynergy was visually judged in the core 
laboratory of Kanazawa University by four nuclear 
medicine specialists. A total of 5040 segments were 
analyzed by these four specialists. Quantitative data 
from QGS and QPS were hidden for the visual image 
interpretation. Before interpretation, four interpreters 
gathered several times, interpreted the same sets of 
sample studies, and discussed how to reach the uniform 
five-grade scoring criteria. In addition, 760 segments of 
38 studies were analyzed independently by four 
interpreters, and inter-observer reproducibility was 
examined. Based on this test run, interobserver 
agreement among the four interpreters (6 combinations) 
showed weighted kappa values of 0.81 (95% confidence 
interval [CI], 0.78-0.83) to 0.86 (0.84-0.88) for 
perfusion defect scores and 0.75 (0.72-0.78) to 0.82 
(0.80-0.84) for wall motion scores.  
 
Quantitative analysis 
All of the quantitative analyses were 
performed using the same software and conditions in 
one laboratory. Quantitative perfusion data used average 
perfusion values (%) in 20 segments by QPS software. 
Wall motion (mm) and wall thickening (%) were also 
calculated by QGS software. A normal database 
pre-installed in QPS and QGS was not used, and only 
average values in each segment were utilized for the 
segmental analysis.  
 
Analysis for viability assessment 
Regarding parameters for predicting motion 
improvement, non-gated %uptake values on QPS and 
end-systolic (ES) and end-diastolic (ED) %uptake 
values on QGS were used. Visual scoring was 
performed without these quantitative data. The abnormal 
wall motion before intervention was defined by a visual 
motion score of 2 to 4 and/or a quantitative thickening 
value of <32% [16, 17]. We used wall thickening values 
in the 20-segment model as an adjunct for asynergy 
assessment. After intervention, since CABG was 
included in 17% of cases, septal motion showed 
abnormality even with good wall thickening [18, 19]. 
We therefore determined that the motion was improved 
after reperfusion if the percentage of wall thickening 
was improved to >32%. The segments having abnormal 
wall motion in the reperfused coronary territory were 
analyzed. Number of viable segments defined by the 
appropriate threshold count, which was 63% for 
non-gated map and 52% for ES map based on the results, 




The results were expressed by mean and 
standard deviation (SD). The inter-observer 
reproducibility of the regional wall motion score and 
visual perfusion score were assessed using a weighted 
kappa value and their 95% confidence intervals, with 
quadratic weighting assignment [20]. Statistics of 
sensitivity, specificity, accuracy, and positive and 
negative predictive values for predicting wall motion 
improvement were calculated with respect to the 
perfusion parameters. Receiver operating characteristics 
curves (ROCs) were generated, and the area under the 
curve (AUC) and optimal threshold were determined. 
The ROC curve was also analyzed to determine AUCs 
in subgroups of coronary artery stenosis and 
revascularization. The significance of the differences in 
cardiac function between before and after 
revascularization was assessed by paired t test. The 
significance of the differences in viability markers 
between improved and non-improved groups was 
assessed by unpaired t test for parametric variables and 
Wilcoxon rank-sum test for non-parametric variables. 
To compare AUCs among different predictors, a 
nonparametric method was used [21]. Multiple 
comparison tests were adjusted with a Bonferroni 
correction. All statistical tests were two-tailed, and a p 
value of <0.05 was considered significant. SAS System 





Improvement of regional segmental asynergy 
 At least one mild hypokinesis was observed 
in 125 patients (50%), severe hypokinesis in 187 
patients (74%), akinesis in 113 patients (45%) and 
dyskinesis in 20 patients (8%). A total of 1730 segments 
(33%), in which coronary revascularization was 
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performed, were analyzed. Segmental asynergy was 
improved in 360 segments (21%) and not improved in 
1370 segments (79%). The %uptake values on 
non-gated, ES and ED perfusion maps are summarized 
in Table 2. Before revascularization, non-gated %uptake 
was 66±17% and 55±18% for improved and 
non-improved groups, respectively (p<0.0001). The 
ES %uptake was 64±16% and 51±17% for improved 
and non-improved groups, respectively (p<0.0001). 
When %uptake was compared before and after 
revascularization in the improved group, it improved by 
+9%, +10% and +3% units for non-gated, ES and ED 
perfusion maps, respectively (p<0.0001). In contrast, 
the %uptake improved by +3% units for non-improved 
groups using the three maps. The %wall thickening 
increased by +14% (p<0.0001) in the improved group, 
while it increased by only +1% in the non-improved 
group.  Average perfusion defect score decreased from 
1.0 to 0.3 in the improved group (p<0.0001 by 
Wilcoxon test). In the non-improved group, the mean 
score slightly decreased from 1.3 to 0.9 after 
revascularization (p<0.0001). Before the 
revascularization, visual perfusion defect score was 
slightly smaller in the improved group than in the 
non-improved group (p=0.0006). 
 Figure 1 shows a patient with old 
myocardial infarction in the anteroseptal and inferior 
walls, and perfusion and thickening were improved after 
coronary stenting. He had risk factors of hypertension, 
diabetes mellitus and current smoking. EF increased 
from 35% to 53%, and EDV was improved from 163 to 
135 mL.  
 
ROC analysis for the predictors of motion improvement 
When diagnostic ability was evaluated by 
the parameters of %uptake by non-gated perfusion and 
ES and ED perfusion maps, the AUCs were 0.70, 0.71 
and 0.61, respectively, whereas the AUC by visual 
scoring was the lowest (0.56) (Figure 2). The AUC of 
both non-gated and ES %uptake was significantly 
higher than that of ED %uptake (p<0.0001). No 
significant difference was found between non-gated and 
ED %uptake maps. 
When the AUC was calculated in each 
coronary artery territory regarding %uptake on 
non-gated perfusion map, LAD, LCX and RCA 
territories were 0.71, 0.66 and 0.73, respectively and 
that on the ES perfusion map was 0.71, 0.70 and 0.73, 
respectively (Table 3). The RMI patients showed 
slightly lower AUC value than OMI patients. Patients 
who underwent revascularization in 1, 2 and 3 vessels 
showed similar AUC values of 0.71-0.72 for non-gated 
perfusion map, and 0.74, 0.72 and 0.70 for ES perfusion 
map. The type of revascularization, namely PCI and 
CABG, showed AUC values from 0.70 to 0.73 and did 
not differ significantly.  
 
Diagnostic accuracy based on the optimal threshold 
The optimal threshold value was determined 
by the point on the ROC curve where the sum of 
sensitivity and specificity was maximal. When the 
optimal %uptake of 63% was used for the non-gated 
perfusion map, the sensitivity, specificity and accuracy 
for predicting wall motion recovery were 68%, 64% and 
65%, respectively (Table 4). When an optimal %uptake 
of 52% was used for the ES perfusion map, they were 
80%, 52% and 58%, respectively. The AUC was 
comparable for the non-gated map (0.70) and %ES map 
(0.71). When optimal %uptake of 43% on the ED 
perfusion map was used, they were 63%, 54% and 56%, 
respectively. For visual analysis with the optimal cutoff 
of score 1, the sensitivity, specificity and accuracy were 
70%, 41% and 47%. 
 
Changes of global function after revascularization 
Ejection fraction (EF) in this study ranged 
from 11% to 81%, with an average of 50%±15%. 
Average EFs were significantly improved after 
revascularization: 50±15% and 53±14% before and after 
revascularization, respectively (p<0.0001, paired T test). 
Average EDV and ESV were 103±47 mL and 56±42 
mL in the first study, and the volumes were significantly 
reduced to 96±45 mL and 49±37 mL after 
revascularization, respectively (p<0.0001 for both).  
When non-gated %uptake and ES %uptake 
were compared with respect to baseline EF before 
revascularization and improvement in EF >5%, 28% of 
patients with baseline EF >50% and 42% of patients 
with EF <50% showed improvement (Table 5). EF and 
wall thickening were also written for comparison. In the 
group of improved EF, mean EF and mean %thickening 
increased significantly (p<0.0001). When the segment 
of minimal %uptake was observed in this group, both 
mean non-gated and ES %uptake values increased 
significantly. Conversely, in the non-improved group 
with baseline EF >50%, both non-gated %uptake and 
ES %uptake values did not increase. In patients with EF 
<50%, however, although %uptake was slightly 
increased in the non-improved group, EF and % wall 
thickening did not change significantly.  
When predictors of EF improvement >5% 
were analyzed, the optimal minimal %uptake was 41% 
for the non-gated map and 34% for ES %uptake (Table 
6).  Based on these threshold criteria of %uptake, 
sensitivity and specificity were 57% and 62% for 
non-gated %uptake values, while they were 54% and 
64% for ES %uptake. The optimal number of viable 
segments was defined as >2 segments of %uptake >63% 
for non-gated map, and >3 segments of %uptake >52% 
for ES map. When number of viable segments was used 
as the predictor of improvement in EF, sensitivity and 
specificity were 67% and 48% for non-gated %uptake 
and 60% and 55% for ES %uptake. Negative predictive 
value was 0.72-0.73 for both non-gated and ES %uptake. 




This study was a multicenter cohort study 
for viability assessment using quantitative gated SPECT 
involving 25 hospitals. We confirmed the role of 
99mTc-MIBI gated SPECT for predicting functional 
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recovery after myocardial infarction. Quantitative 
assessment derived from ES perfusion and non-gated 
perfusion maps showed higher diagnostic accuracy 
compared with the conventional visual assessment of 
perfusion defect scoring. Subanalysis with respect to the 
number of revascularized coronary vessels, coronary 
territory and revascularization type showed comparable 
diagnostic accuracy for viability assessment. As a 
predictor of functional recovery, the aid of quantitative 
assessment with gated SPECT showed a higher 
diagnostic value than visual segmental evaluation, and 
would be recommended particularly for multi-center 
studies. 
 
Precedent studies on viability assessment 
 Assessment of myocardial viability after 
myocardial infarction has been considered vital for 
indicating coronary revascularization, and a number of 
studies have evaluated predictive values of 99mTc-MIBI 
for wall motion recovery in the US and European 
counties [8, 12, 22-24]. Histological basis was given by 
Maes et al., who found a linear relation between percent 
fibrosis and MIBI uptake [10]. Considering that 
Japanese patients have different backgrounds for risk 
factors and lower cardiac hard event rate, we designed 
this multi-center cohort study with a larger number of 
patients [25, 26]. Our study showed that sensitivity and 
specificity of functional recovery by non-gated %uptake 
were 68% and 64%, and those of ES %uptake were 80% 
and 52%, showing higher sensitivity of %ES uptake. 
According to the meta-analysis by Bax et al. sensitivity 
and specificity of SPECT from 7 99mTc-MIBI studies 
were 81% (191/236) and 60% (122/203) [5]. Specificity 
varied from 35% to 86% in spite of a high sensitivity 
from 73% to 100%. The present study also showed 
comparable values for diagnostic accuracy, and slightly 
different characteristics of each quantitative predictor. 
 
Characteristics of the present study 
 This study was based on a multi-center 
cohort study involving 25 Japanese institutions and 252 
patients. The predictive values of AUC, sensitivity and 
specificity were comparable or slightly lower than the 
precedent investigations [5, 8, 12]. However, ours were 
comparable with the results by Acampa et al. using 
sublingual nitrate administration [9]. Few studies have 
used 20-segment-based wall motion evaluation and a 
5-grade scoring method in viability studies. From the 
SPECT image interpretation to assessment of predictors, 
we used aids of displays from quantitative software, 
here with QGS and QPS. Since many institutions 
participated in this study, some differences in 
preferences for acquisition and processing should be 
overcome by the use of quantitative software [27].  
The demographics of the patients showed 
less severe profiles compared with those of the 
precedent studies. Mean EFs were 34±10% by Udelson 
et al. [8] and 36±9% by Kang et al. [12], and those in 
most studies were from 30% to 50% [5]. In contrast, our 
study population showed mean EF of 50% and mean 
EDV of 103 mL before revascularization, average 
segmental %uptake of 66% and 55% for improved and 
non-improved groups, and mean visual perfusion defect 
score of 1 and 1.3 for improved and non-improved 
groups, respectively. In addition, 56% of patients had 
one-vessel disease. The less severe profile might have 
resulted in a modest predictive accuracy. 
 
Optimal threshold values  
The optimal threshold values in this study 
were 63% of the peak activity for non-gated %uptake 
and 52% for ES %uptake. Udelson et al. found that 201Tl 
and 99mTc-MIBI regional activities were similar in 
segments with reversible (72 ± 11% versus 75 ± 9%, 
respectively) as well as irreversible ventricular 
dysfunction (51 ± 11% versus 50 ± 8%) [8]. The cutoff 
value to separate reversible from irreversible segments 
was approximately 60%. A difference of 25% of peak 
activity between reversible and irreversible segments 
was found in their study, while our study showed a 
difference of 11% by non-gated polar map. Acampa et 
al. also found that the optimal threshold values to 
separate reversible from irreversible dysfunction, as 
determined by ROC analysis, were 55% of peak activity 
for both tetrofosmin and MIBI and 60% for 201Tl [9]. 
Maes et al. also found an optimal threshold value of 
50% for prediction of functional recovery [10]. We 
could note that the optimal threshold of ED %uptake 
was lower (43%), and the diagnostic ability was lower 
than that of ES %uptake. Thus, we should have referred 
to the average count derived from the ES map, although 
the use of ES %uptake is not so common. 
 
Subgroup analysis for predicting functional recovery 
 The subgroup analyses for the number of 
stenotic arteries, the location of revascularized coronary 
arteries and type of revascularization showed similar 
AUC by non-gated and ES %uptake values, indicating 
the validity of these predictors for viability assessment. 
When we observed the coronary artery territory by 
non-gated %uptake perfusion map, AUC of the LCX 
was lower than that of the LAD and RCA regions, 
whereas ES %uptake showed comparable values for all 
coronary regions. Therefore, use of ES %uptake seemed 
to enhance the diagnostic ability for predicting wall 
motion recovery of the LCX region. Ibrahim et al. also 
reported that sensitivity of MIBI SPECT for detecting 
old myocardial infarction was slightly lower in the LCX 
territory (79%), compared with LAD (89%) and RCA 
(87%) territories. This might partly be explained by the 
underestimation of LCX ischemia by the anatomically 
smaller perfusion area or relatively high uptake in the 
lateral wall in non-attenuation corrected images. 
Moreover, considering image resolution of conventional 
SPECT systems with a full-width at half-maximum of 
~15mm, partial volume effect is smaller in the ES phase 
than in the ED phase or non-gated images. The blurring 
of images due to a larger motion of the free wall may 
also be a concern.  
 
Predictors of improvement in global function 
Few studies have evaluated the global 
Multi-center viability study with Tc-99m MIBI                            - 6 - 
functional improvement as detected by EF [5]. 
Improvement of global EF was clinically important as 
well as recovery of regional wall motion. Therefore, we 
investigated the predictive value of myocardial 
perfusion to achieve >5% of EF improvement.  The 
AUCs for non-gated and ES %uptake values were ~0.60 
for predicting EF improvement, whereas they were 
~0.70 for predicting regional improvement. This 
indicated that regional improvement did not readily 
reflect global functional improvement.  
Slight increase in myocardial perfusion 
might not result in significant improvement in wall 
motion. Table 5 showed that in patients with EF 
<50%, %uptake was slightly increased, but EF and wall 
thickening were not. In this respect, importance of the 
amount of viable myocardium was also demonstrated 
[12]. They found that the number of viable segments in 
rest 201Tl uptake was a predictor of improvement, which 
was associated with 20-25% of the viable myocardium. 
The number of viable segment required for functional 
recovery was 2-3 segments for each coronary artery 
territory in our study, which corresponded to 30-40% 
area of each coronary artery territory, and showed 
comparable AUC values with %minimal uptake per 
segment.  
The background of the patients was also 
concerned. Only one third of the patients showed 
improvement in EF >5%, and OMI was observed in 
approximately 70% of the patients in our study 
population. Although jeopardized myocardium after 
ischemic episodes could recover after appropriate 
therapy, the completed infarction might not have 
benefited directly from the revascularization. The 
follow-up period was not long enough (132 days) to 
obtain final outcome of revascularization, and further 
improvement in global function may have been possible 
after 4 months. Finally, the fundamental issue depends 
on the definition of viability, namely myocardial 
perfusion restoration and thickening improvement may 
not have been identical [28].  
 
Limitations 
 The first limitation was concerned with the 
multi-center study involving 25 hospitals. Although 
standard acquisition protocol was used in each hospital, 
the technical and protocol-based preferences among 
institutions differed to some extent. The effect of 
revascularization procedures regarding PCI and CABG 
was also averaged in many hospitals. However, this 
study reflected actual clinical practice of 
revascularization in Japan. Therefore, although the 
diagnostic accuracy was slightly lower than that of the 
precedent studies, the variability reflected one of the 
worst scenarios from the viewpoint of technical 
concordance. The superiority of the quantitative method 
was also explained by the difference in preference and 
interpretation of the diverse quality images. In addition, 
restenosis was confirmed by coronary arteriography in 
71% of the patients, which may partly have influenced 
the results. However, since the number of patients in 
whom no restenosis was confirmed was 87 (69%) for 
the improved group and 118 (72%) for the 
non-improved group, no bias for either of the groups 
was observed.  
 We used 20-segment model for 
quantification that was validated well at that time, and 
the model depended on the software version. However, 
comparable results will be obtained by the 17-segment 
model [15]. The non-improved group included patients 
with normal EF, and those with relatively high EF 
before revascularization might not show significant 
increase in EF after revascularization. In other words, 
revascularization procedure would be more beneficial 
for patients with low EF.   
 In spite of these limitations, we confirmed 
the usefulness of gated SPECT for functional recovery 
in the multicenter study. The quantitative evaluation was 





 Gated SPECT was performed at rest using 
99mTc-MIBI in 252 patients from 25 institutions. The 
predictive accuracy of myocardial uptake for regional 
and global left ventricular functional improvement was 
evaluated. A higher predictive accuracy was obtained by 
ES %uptake and non-gated %uptake than visual scoring 
of perfusion defects. Subgroups analysis regarding 
coronary artery stenosis, the number of revascularized 
vessels and types of revascularization showed 
comparable diagnostic performances. Thus, application 
of quantitative gated SPECT information enhanced 
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Japan Mutual Aid Association of Public School Teachers, 
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Fig. 1  
A 70-year-old male patient with old myocardial infarction in the anteroseptal and inferior walls. RCA mid segment 
(segment 2) showed stenosis of 90% and was improved to 0% after stenting. Proximal LAD stenosis (segment 6) of 
75% was also improved to 0% after stenting. Stenosis of LCX posterolateral branch (segment 14, 75%) was not 
revascularized. Before revascularization, mid to apical anteroseptal regions (white arrows) and the inferior region 
(blue arrows) showed hypoperfusion, which corresponded to the LAD and RCA stenosis. Changes in perfusion and 
thickening were evident in the ES perfusion and wall thickening maps, particularly in the anteroseptal region. 
Improvement in global EF and volumes could be also noted. 
 
 
Fig. 2  
ROC curves for %uptake on non-gated perfusion, end-systolic (ES) perfusion and end-diastolic (ED) perfusion maps, 
and visual perfusion score for predicting functional improvement of segmental asynergy after revascularization. The 
AUCs were 0.70 (95% CI, 0.67-0.73), 0.71 (0.68-0.74), 0.61 (0.58-0.64) and 0.56 (0.52-0.59), respectively. 
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Table 1  Demographics of 252 patients 
    number % 
Gender male 216 86% 
Type of infarction RMI 74 29% 
 OMI 175 69% 
 RMI and OMI 3 1% 
No. of diseased vessels 1 140 56% 
 2 59 23% 
 3 53 21% 
Type of revascularization PCI  210 83% 
 CABG  40 16% 
 PCI and CABG  2 1% 
Stenotic lesion LAD 150 60% 
 LCX 70 28% 
  RCA 117 46% 
Abbreviations: RMI, recent myocardial infarction; OMI , old myocardial infarction;  
PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; 
LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery;  
RCA, right coronary artery 
 
 
Table 2 Comparison of viability predictors between segment groups with and without regional improvement 
before and after revascularization  
Predictors Improved Not improved P value (unpaired) 
Number of segments 360 1370  
%uptake on non-gated map   
  Before 66±17 55±18 ＜0.0001 
  After 75±11 58±17 ＜0.0001 
  P value (paired) ＜0.0001 ＜0.0001  
%uptake on ES map    
  Before 64±16 51±17 ＜0.0001 
  After 74±11 54±16 ＜0.0001 
  P value (paired) ＜0.0001 ＜0.0001  
%uptake on ED map    
  Before 47±12 42±13 ＜0.0001 
  After 50±9 45±13 ＜0.0001 
  P value (paired) ＜0.0001 ＜0.0001  
% wall-thickening on polar  map   
  Before 30±13 16±10 ＜0.0001 
  After 44±12 17±9 ＜0.0001 
  P value (paired) ＜0.0001 ＜0.0001   
Abbreviations: ES, end-systocic; ED, end-diastoic 
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Table 3  ROC analyses and AUC in subgroups of patients  
    No. of segments non-gated % uptake ES % uptake 
    (n=1730) AUC 95% CI AUC 95% CI 
Types of infarction     
 RMI 482 0.66 0.59-0.73 0.69 0.63-0.75 
 OMI 1248 0.71 0.68-0.74 0.72 0.68-0.75 
Revascularized artery     
 LAD 960 0.71 0.67-0.75 0.71 0.68-0.75 
 LCX 296 0.66 0.57-0.75 0.70 0.62-0.78 
 RCA 474 0.73 0.68-0.80 0.73 0.67-0.79 
No. of revascularized artery     
 1 vessel 735 0.72 0.68-0.76 0.74 0.71-0.78 
 2 vessels 404 0.71 0.65-0.77 0.72 0.66-0.78 
 3 vessels 591 0.71 0.65-0.77 0.70 0.64-0.76 
Type of revascularization     
 PCI 1223 0.70 0.64-0.77 0.73 0.70-0.76 
  CABG 507 0.71 0.68-0.75 0.70 0.63-0.76 
Abbreviations: ROC, receiver operating characteristics; AUC, area under the curve; CI, confidence interval 
 
 
Table 4  Diagnostic accuracy and AUC of  % uptake for predicting regional  
functional improvement after revascularization 
Patient-based statistics Non-gated map ES map 
Optimal threshold for %uptake* 63% 52% 
Sensitivity 68% (243/360) 80% (289/360) 
Specificity  64% (882/1370)  52% (712/1370) 
PPV 33% (243/731) 31% (289/947) 
NPV 88% (882/999) 91% (712/783) 
Accuracy    65% (1125/1730)    58% (1001/1730) 
AUC 0.70 0.71 
* the segmental %uptake to the maximal count 
Abbreviations: PPV, positive predictive value; NPV, negative predictive value; AUC, area under the curve 
Multi-center viability study with Tc-99m MIBI                            - 12 - 
Table 5 Comparison of viability predictors and LVEF between patient  groups with  
 and without global EF improvement (>5% EF unit) 
  Baseline EF >50% Baseline EF <50% 
  Improved Not improved Improved Not improved 
Number of patients 39 (28%) 100 (72%) 48 (42%) 65 (58%) 
%uptake of the minimal segment on non-gated map   
  Before 42±14 48±12 35±18 35±15 
  After 48±12 49±11 42±15 40±16 
  P value (paired) 0.0068 n. s. 0.0016 0.0004 
%uptake of the minimal segment on ES map   
  Before 37± 9 42±11 31±15 33±12 
  After 42±12 43±10 39±13 36±13 
  P value (paired) 0.0014 n. s. 0.0006 0.0037 
EF (%)     
  Before 58± 7 62± 8 35±10 39± 9 
  After 68± 7 60± 9 47±12 38± 9 
  P value (paired) ＜0.0001 ＜0.0001 ＜0.0001 n. s. 
%wall thickening of the minimal segment   
  Before 12± 8 16± 9  3± 6 4± 6 
  After 20±13 14± 8 10± 7 4± 6 
  P value (paired) ＜0.0001 0.0079 ＜0.0001 n. s. 
Abbreviation: EF, ejection fraction 
 
 
Table 6 Diagnostic accuracy and AUC of %uptake and number of viable segments for predicting EF 
improvement >5% after revascularization 
Patient-based The minimal % uptake/segment No. of viable segments 
statistics Non-gated map ES map Non-gated map ES map 
Optimal threshold 41%* 34%* >2 segments** >3 segments*** 
Sensitivity 57% (50/87) 54% (47/87) 67% (52/87) 60% (52/87) 
Specificity 62% (102/165) 64% (106/165) 48% (91/165) 55% (91/165) 
PPV 44% ( 50/113) 44% (47/106) 41% ( 58/143) 41% (52/126) 
NPV 73% (102/139) 73% (106/146) 73% (80/109) 72% (91/126) 
Accuracy 60% (152/252) 61% (153/252) 55% (138/252) 57% (143/252) 
AUC 0.60 0.60 0.59 0.58 
* the minimal segmental %uptake to the maximal count, ** the viable segment with non-gated % uptake of >63%, *** 
the viable segment with ES % uptake of >52%    
 
